J Endocr Surg.  2021 Dec;21(4):111-117. 10.16956/jes.2021.21.4.111.

Reduced Port Robotic Bilateral Axillo-Breast Approach (BABA) Isthmusectomy

Affiliations
  • 1Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
  • 2Department of Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY, USA
  • 3Department of Surgery, Seoul National University College of Medicine, Seoul, Korea
  • 4Department of Surgery, Seoul National University Hospital, Seoul, Korea
  • 5Department of Surgery, Seoul Metropolitan Government-Seoul National University Boramae Medical Center and College of Medicine, Seoul, Korea

Abstract

Purpose
To investigate whether reduced port robotic bilateral axillo-breast approach (BABA) surgery can be a safe alternative approach for patients undergoing isthmusectomy for well differentiated papillary thyroid cancer confined to the isthmus.
Methods
A total of 45 patients with well differentiated papillary thyroid cancer confined to the isthmus underwent reduced port robotic BABA isthmusectomy by a single surgeon from March 1st 2020 to November 30th 2021. The left areolar port was omitted in all cases of surgery. Patients’ records were reviewed to determine surgical adequacy and whether if the surgery was feasible.
Results
The average operation time was 71.02 minutes (range, 37–108 minutes; standard deviation [SD], 16.22 minutes). Patients were discharged at an average of 2.15 days after surgery. There were no cases of vocal cord palsy or hypocalcemia. An average of 3.95 (range, 0–11; SD, 2.80) central lymph nodes were obtained per surgery.
Conclusion
Reduced port robotic BABA surgery is a feasible and safe alternative option for thyroid isthmusectomy. However, a thorough pre-operative evaluation is needed for selecting adequate patients.

Keyword

Robot surgery; Thyroidectomy; Thyroid neoplasms; Feasibility studies; Treatment outcome
Full Text Links
  • JES
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr